![]() |
市場調查報告書
商品編碼
2032648
顱內支架市場報告:按類型、應用、最終用戶和地區分類(2026-2034 年)Intracranial Stents Market Report by Type (Self-Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization), Application (Intracranial Stenosis, Brain Aneurysm), End User (Hospitals, Ambulatory Surgery Centers), and Region 2026-2034 |
||||||
2025年全球顱內支架市場規模達5.217億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到12.402億美元,2026年至2034年的複合年成長率(CAGR)為9.80%。推動市場成長的主要因素包括:各種腦血管疾病的盛行率不斷上升、人口快速老化以及患者和醫療專業人員對非侵入性和微創手術的日益青睞。
顱內支架是一種小型管狀醫療設備,由鎳鈦合金或不銹鋼等生物相容性材料製成,專門用於以微創方式治療各種腦血管疾病。它們與多種影像技術具有良好的兼容性,能夠精準地在血管內導航並到達目標部位。此外,它們還有多種尺寸和形狀可供選擇,以適應不同的解剖結構。最常見的應用是將支架置於腦部狹窄或脆弱的血管中,以提供結構支撐並恢復血流。透過維持血管通暢性,它們可以改善腦部血流,並有助於降低中風和其他與血管狹窄或損傷相關的併發症的風險。顱內支架廣泛應用於血管成形術和血管內彈簧圈栓塞術等手術和治療中,用於治療包括顱內動脈瘤和狹窄在內的各種疾病。顱內支架的優點包括為血管提供長期支撐、縮短恢復時間和減少住院時間。
全球市場的主要驅動力是各種腦血管疾病(包括腦動脈瘤和中風)發生率的上升。這主要是由於老年人口的快速成長,而老年人更容易患上這些疾病。同時,顱內支架製造技術的不斷進步催生了具有更高柔軟性、操控性和徑向支撐力的創新先進產品,從而推動了市場成長。此外,人們越來越重視神經系統疾病的早期診斷和治療,這促使人們對有效的治療方案的需求增加,進而推動了顱內支架的普及。患者和醫療專業人員傾向於選擇恢復時間較短的非侵入性和微創手術,這也是市場成長的關鍵促進因素。此外,一些國家的政府機構和私人保險公司對顱內支架手術的優惠報銷政策也提振了市場前景。各大公司之間為擴大市場影響而進行的各種策略聯盟、併購和夥伴關係也進一步促進了市場發展。此外,磁振造影(MRI)、電腦斷層掃描(CT)和血管造影術等醫學影像技術的眾多創新也對市場產生了積極影響。其他推動市場發展的因素包括快速的都市化、不斷上漲的醫療成本、醫院基礎設施的改善(尤其是在開發中國家)以及廣泛的研發活動。
The global intracranial stents market size reached USD 521.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,240.2 Million by 2034, exhibiting a growth rate (CAGR) of 9.80% during 2026-2034. The rising prevalence of various cerebrovascular disorders, rapidly growing geriatric population, and shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures represent some of the key factors driving the market.
Intracranial stents refer to small, tubular medical devices that are made from biocompatible materials such as nitinol or stainless steel, specifically designed for treating various cerebrovascular conditions in a less invasive way. They are characterized by improved compatibility with multiple imaging techniques, allowing precise navigation through blood vessels and are therefore deployed at the target site, with various sizes and configurations available to accommodate individual anatomical features. They are most commonly installed within narrowed or weakened blood vessels in the brain to provide structural support and restore blood flow. By maintaining vessel patency, they provide enhanced blood flow to the brain which helps in reducing the risk of stroke and other complications associated with restricted or damaged blood vessels. Intracranial stents find extensive applications i7surgeries and procedures such as angioplasty or endovascular coiling, to treat various conditions including intracranial aneurysms or stenosis. Some of the advantages provided by intracranial stents include long-term support to blood vessels, shorter recovery times, and reduced hospital stays.
The global market is primarily driven by the rising prevalence of various cerebrovascular disorders such as cerebral aneurysms and strokes. This can be attributed to the rapidly growing geriatric population that is more susceptible to developing these ailments. In line with this, continual technological advancements in intracranial stent production resulting in innovative and advanced products with improved flexibility, navigability, and radial strength are fueling the market. Moreover, an enhanced emphasis on early diagnosis and treatment of neurological conditions is propelling the demand for effective treatment solutions, which in turn is resulting in a higher uptake of intracranial stents. Also, the shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures with shorter recovery times is acting as a significant growth-inducing factor for the market. In addition to this, favorable reimbursement policies for intracranial stent procedures by government agencies and private insurance providers in several countries is creating a positive market outlook. The market is further fueled by various strategic collaborations, merger and acquisitions (M&As) and partnerships among key players to expand their market presence. Apart from this, numerous innovations in medical imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and angiography are impacting the market positively. Some of the other factors contributing to the market include rapid urbanization, rising healthcare expenditure, upgradation of hospital infrastructure, particularly in developing countries and extensive research and development (R&D) activities.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intracranial stents. Some of the factors driving the North America intracranial stents market included growing geriatric population, continual technological advancements, shifting preference towards non-invasive and minimally invasive procedures, high healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global intracranial stents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Acandis GmbH, Balt Group, Medtronic Public Limited Company, MicroPort Scientific Corporation, Phenox GmbH, Stryker Corporation, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.